1. Q8-R1. Pharmaceutical Development, Draft 7.0. ICH; 8 August 2007.
2. Potter C, et al. A guide to EFPIA’s Mock P.2 document. Pharm Technol 2006.
3. Ende D, et al. API quality by design example from the torcetrapib manufacturing process. J Pharm Innov. 2007;2:71–86.
4. Seibert KD, et al. The use of routine process capability in the determination of PARs, CPPs, and mapping of the design space in a API process, AIChE Annual Meeting, Salt Lake City, UT, Nov. 2007.
5. Glodek M, et al. Process robustness—A PQRI white paper. Pharm Eng. 2006;26 6:1–11.